Nycomed’s Lung Drug Daxas Launched In Germany, UK Is Next – Automated Trader
Nycomed's Lung Drug Daxas Launched In Germany, UK Is Next Automated Trader Nycomed said 700000 people in Germany currently suffer from COPD and chronic bronchitis. According to World Health Organization estimates, some 80 million ... From Oranienburg to the rest of the world: global market launch of Daxas ...PharmaLive (press release) (subscription) all 4 news articles » |